pubmed-article:19925018 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C0001138 | lld:lifeskim |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C0597979 | lld:lifeskim |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C0233820 | lld:lifeskim |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
pubmed-article:19925018 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
pubmed-article:19925018 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:19925018 | pubmed:dateCreated | 2010-1-12 | lld:pubmed |
pubmed-article:19925018 | pubmed:abstractText | The need to develop beta-lactamase inhibitors against class C cephalosporinases of Gram-negative pathogens represents an urgent clinical priority. To respond to this challenge, five boronic acid derivatives, including a new cefoperazone analogue, were synthesized and tested against the class C cephalosporinase of Acinetobacter baumannii [Acinetobacter-derived cephalosporinase (ADC)]. The commercially available carbapenem antibiotics were also assayed. In the boronic acid series, a chiral cephalothin analogue with a meta-carboxyphenyl moiety corresponding to the C(3)/C(4) carboxylate of beta-lactams showed the lowest K(i) (11 +/- 1 nM). In antimicrobial susceptibility tests, this cephalothin analogue lowered the ceftazidime and cefotaxime minimum inhibitory concentrations (MICs) of Escherichia coli DH10B cells carrying bla(ADC) from 16 to 4 microg/mL and from 8 to 1 microg/mL, respectively. On the other hand, each carbapenem exhibited a K(i) of <20 microM, and timed electrospray ionization mass spectrometry (ESI-MS) demonstrated the formation of adducts corresponding to acyl-enzyme intermediates with both intact carbapenem and carbapenem lacking the C(6) hydroxyethyl group. To improve our understanding of the interactions between the beta-lactamase and the inhibitors, we constructed models of ADC as an acyl-enzyme intermediate with (i) the meta-carboxyphenyl cephalothin analogue and (ii) the carbapenems, imipenem and meropenem. Our first model suggests that this chiral cephalothin analogue adopts a novel conformation in the beta-lactamase active site. Further, the addition of the substituent mimicking the cephalosporin dihydrothiazine ring may significantly improve affinity for the ADC beta-lactamase. In contrast, the ADC-carbapenem models offer a novel role for the R(2) side group and also suggest that elimination of the C(6) hydroxyethyl group by retroaldolic reaction leads to a significant conformational change in the acyl-enzyme intermediate. Lessons from the diverse mechanisms and structures of the boronic acid derivatives and carbapenems provide insights for the development of new beta-lactamase inhibitors against these critical drug resistance targets. | lld:pubmed |
pubmed-article:19925018 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:language | eng | lld:pubmed |
pubmed-article:19925018 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19925018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19925018 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19925018 | pubmed:month | Jan | lld:pubmed |
pubmed-article:19925018 | pubmed:issn | 1520-4995 | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:McDavidGG | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:CaselliEmilia... | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:BonomoRobert... | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:DistlerAnne... | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:PratiFabioF | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:BethelChristo... | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:DrawzSarah... | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:BabicMajaM | lld:pubmed |
pubmed-article:19925018 | pubmed:author | pubmed-author:TaracilaMagda... | lld:pubmed |
pubmed-article:19925018 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19925018 | pubmed:day | 19 | lld:pubmed |
pubmed-article:19925018 | pubmed:volume | 49 | lld:pubmed |
pubmed-article:19925018 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19925018 | pubmed:authorsComplete | Y | lld:pubmed |